At the conclusion of this continuing education activity, the participant will be able to:
Describe the requirements of the Controlled Substance Act as it relates to the community pharmacy
Review best practices for controlled substances throughout their pharmacy lifecycle
Review the CMEA (Combat Methamphetamine Epidemic Act) and updates to buprenorphine dispensing